Effect of Extracorporeal Shockwave Therapy on Pruritus in Neurodermatitis Patients

Cairo University (CU)

Status: Completed

Conditions: Neurodermatitis

Treatments: Device: Shockwave therapy; Drug: Emollients & corticosteroids

Study type: Interventional

Funder types: Other

Identifiers

NCT07206680

P.T.REC/012/005978

Details and patient eligibility

About

The purpose of this study is to evaluate the therapeutic effect of shockwave therapy on reducing pruritus in neurodermatitis patients.

Full description

Based on the occurrence of side effects caused by conventional medication for prolonged employment, dermatologists and patients show solicitude for multifaceted effective methods to control the chronic and relapsing nature of neurodermatitis.

Although new modalities are continuously coming up for pruritus, there remains a great gap for providing symptom relief.

Furthermore, there is a lack in the quantitative knowledge and information in the published studies about benefits of shockwave therapy on the treatment of pruritus in neurodermatitis patients. So, this study is designed to outline the therapeutic efficacy of shockwave therapy on the treatment of pruritus in neurodermatitis patients.

Enrollment: 34 patients

Sex: All

Ages: 55 to 75 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age range between 55:75 years.
• Male and female patients will participate in the study.
• All patients have neurodermatitis.
• All patients will be received the same approach of medication and nursing care.
• All patients enrolled in the study will have their informed consent.

Exclusion criteria

• Patients diagnosed with cancer.
• Pregnant woman.
• active infection.
• Patients with any systemic diseases that may interfere with the objectives of the study.
• Cardiac pacemakers or other implantable devices.
• Current anticoagulation use.
• Any other cause of itching

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

34 participants in 2 patient groups

Shockwave therapy + corticosteroids + emollients

Experimental group

Description:

It will include 17 patients suffering from neurodermatitis who will receive shockwave therapy for 10min, 4 sessions, once per week and emollients \& corticosteroids for a month.

Treatment:

Drug: Emollients & corticosteroids

Device: Shockwave therapy

Corticosteroids & Emollients

Active Comparator group

Description:

It will include 17 patients suffering from neurodermatitis who will receive their emollients \& corticosteroids only for a month.

Treatment:

Drug: Emollients & corticosteroids